Thyrotropin suppressive therapy in thyroid carcinoma: what are the targets?
G Brabant - The Journal of Clinical Endocrinology & Metabolism, 2008 - academic.oup.com
… of thyroid carcinoma support TSH suppressive therapy as the … , or tailored TSH suppression
using sensitive TSH assays (3). … of TSH suppressive treatment in patients with thyroid cancer (…
using sensitive TSH assays (3). … of TSH suppressive treatment in patients with thyroid cancer (…
The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma
KA Heemstra, NAT Hamdy, JA Romijn, JWA Smit - Thyroid, 2006 - liebertpub.com
… deleterious effects of TSH-suppressive therapy on the skeleton remain controversial. Our
aim was to review the literature on the effects of TSH-suppressive therapy on bone metabo- …
aim was to review the literature on the effects of TSH-suppressive therapy on bone metabo- …
Does postoperative thyrotropin suppression therapy truly decrease recurrence in papillary thyroid carcinoma? A randomized controlled trial
I Sugitani, Y Fujimoto - The Journal of Clinical Endocrinology & …, 2010 - academic.oup.com
… Context: TSH suppression therapy has been used to decrease thyroid cancer recurrence. …
(DFS) for papillary thyroid carcinoma (PTC) in patients without TSH suppression is not inferior …
(DFS) for papillary thyroid carcinoma (PTC) in patients without TSH suppression is not inferior …
Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study
I Sugitani, Y Fujimoto - Surgery, 2011 - Elsevier
… postoperative TSH suppressive therapy on disease-free survival for papillary thyroid carcinoma
(PTC) since 1996, while prospectively verifying the effects of TSH suppression on BMD. …
(PTC) since 1996, while prospectively verifying the effects of TSH suppression on BMD. …
The effect of long-term thyroid-stimulating hormone suppressive therapy on the cognitive function of elderly patients with differentiated thyroid carcinoma
JH Moon, S Ahn, J Seo, JW Han, KM Kim… - The Journal of …, 2014 - academic.oup.com
… suppressive therapy on the cognitive function in elderly patients with differentiated thyroid
carcinoma … patients treated with TSH-suppressive therapy compared with control subjects (13). …
carcinoma … patients treated with TSH-suppressive therapy compared with control subjects (13). …
[HTML][HTML] Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma
JL Reverter, S Holgado, N Alonso… - Endocrine-related …, 2005 - erc.bioscientifica.com
… suppressive LT4 treatment does not appear to affect skeletal integrity in women with differentiated
thyroid carcinoma… In conclusion, long-term suppressive LT4 treatment does not appear …
thyroid carcinoma… In conclusion, long-term suppressive LT4 treatment does not appear …
[HTML][HTML] Radioiodine treatment and thyroid hormone suppression therapy for differentiated thyroid carcinoma: adverse effects support the trend toward less aggressive …
ENK Hesselink, TP Links - European Thyroid Journal, 2015 - etj.bioscientifica.com
… Over the past decades, the incidence of differentiated thyroid carcinoma (DTC) has steadily
… adverse effects of radioiodine treatment and thyroid hormone suppression therapy (THST) is …
… adverse effects of radioiodine treatment and thyroid hormone suppression therapy (THST) is …
Thyroid hormone suppression therapy
B Biondi, DS Cooper - Endocrinology and Metabolism Clinics, 2019 - endo.theclinics.com
… thyroid carcinoma: a mouse model of thyroid carcinogenesis. Thyroid. 2002; 12: 963-969 …
perception in patients on thyrotropin-suppressive therapy for differentiated thyroid carcinoma. …
perception in patients on thyrotropin-suppressive therapy for differentiated thyroid carcinoma. …
High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone–Suppressive Therapy for Thyroid Carcinoma
G Mazziotti, AM Formenti, S Frara… - The Journal of …, 2018 - academic.oup.com
… Bone loss and nonvertebral fractures have been reported in patients with differentiated
thyroid carcinoma (DTC) undergoing thyroid-stimulating hormone (TSH) suppressive therapy. …
thyroid carcinoma (DTC) undergoing thyroid-stimulating hormone (TSH) suppressive therapy. …
Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
CH Chen, JF Chen, BY Yang, RT Liu… - Journal of the …, 2004 - europepmc.org
… undergone regular l-T4 suppressive therapy for more than 3 years (… of thyroid-stimulating
hormone (TSH) suppression was … of TSH suppression or duration of l-T4 suppression therapy. …
hormone (TSH) suppression was … of TSH suppression or duration of l-T4 suppression therapy. …
相关搜索
- differentiated thyroid carcinoma suppression therapy
- thyroid carcinoma suppressive levothyroxine therapy
- women with thyroid carcinoma suppressive doses
- thyroid carcinoma bone mineral density
- thyroid carcinoma bone metabolism
- thyroid hormone suppression therapy
- thyrotropin suppression therapy
- thyroid cancer suppressive therapy
- thyroid carcinoma radioiodine therapy
- differentiated thyroid carcinoma bone turnover
- long term tsh suppressive therapy
- postmenopausal women with differentiated thyroid carcinoma
- differentiated thyroid carcinoma radioiodine treatment
- differentiated thyroid carcinoma adverse effects
- thyroid carcinoma suppressive levothyroxine treatment
- patients with differentiated thyroid carcinoma